Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells

Cancer Research

Volumn 66, Issue 19, 2006, Pages 9705-9713

  Tammali, Ravinder ^a   Ramana, Kota V ^a   Singhal, Sharad S ^b   Awasthi, Sanjay ^b   Srivastava, Satish K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; ALDEHYDE REDUCTASE; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN KINASE C BETA; SMALL INTERFERING RNA; SORBINIL; TOLRESTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE PHASE; CELL STRAIN CACO 2; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOCARCINOMA; ALDEHYDE REDUCTASE; ALDEHYDES; ANIMALS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLAST GROWTH FACTOR 2; GLUTATHIONE; HUMANS; IMIDAZOLIDINES; MICE; MICE, NUDE; NEOPLASM PROTEINS; NF-KAPPA B; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE C; RNA, SMALL INTERFERING; S PHASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33750286521     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2105     Document Type: Article

References (47)

1. Fearon ER, Vogelstein BA. Genetic model for colorectal tumorigenesis. Cell 1990;61:759-7.
2. Weinstein IB. Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control. Environ Health Perspect 1991;93:175-9.
3. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden. Cancer 2002;94:2766-92.
4. Kim Y. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 2005;135:2703-9.
5. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001;1:11-21.
6. Marnett LJ, DuBois RN. COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol 2002; 42:55-80.
7. Takahashi T, Takasuka N, Iigo M, et al. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci 2004;95:448-53.
8. Liu W, Reinmuth N, Stoeltzing O, et al. Cyclooxygenase-2 is up-regulated by interleukin-1β in human colorectal cancer cells via multiple signaling pathways. Cancer Res 2003;63:3632-6.
9. Li F, Cao Y, Townsend CM, Jr., Ko TC. TGF-β signaling in colon cancer cells. World J Surg 2005;29:306-11.
10. 2 synthesis in Caco-2 human colon carcinoma cells. Oncogene 2000;19:5517-24.
11. Nakao S, Ogata Y, Yamamoto X Furuyama S, Sugiya H. Platelet-derived growth factor-induced arachidonic acid release for enhancement of prostaglandin E(2) synthesis in human gingival fibroblasts pretreated with interleukin-1β. J Cell Biochem 2004;92:579-90.
12. Tessner TG, Muhale F, Schloemann S, Cohn SM, Morrison A, Stenson WF. Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase. Am J Physiol Gastrointest Liver Physiol 2003;284:G269-79.
13. Dignass AU, Tsunekawa S, Podolsky DK. Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 1994;106:1254-62.
14. Soh JW, Weinstein IB. Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. Prog Exp Tumor Res 2003;37:261-85.
15. Marnett LJ, Kalgutkar AS. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol Sci 1999;20:465-9.
16. Smith ML, Hawcroft G, Hull MA. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 2000;36:664-74.
17. Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Aggarwal BB, Srivastava SK. Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J Biol Chem 2002;277:32063-70.
18. Ramana KV, Bhatnagar A, Srivastava SK. Aldose reductase regulates TNF-α-induced cell signaling and apoptosis in vascular endothelial cells. FEBS Lett 2004; 570:189-94.
19. Ramana KV, Friedrich B, Bhatnagar A, Srivastava SK. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-α in human lens epithelial cells. FASEB J 2003;17:315-7.
20. Bhatnagar A, Srivastava SK. Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem Med Metab Biol 1992;48:91-121.
21. Ramana KV, Dixit BL, Srivastava S, Balendiran GK, Srivastava SK, Bhatnagar A. Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry 2000;9:12172-80.
22. Srivastava SK, Ramana KV, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 2005;26:380-92.
23. Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 1993;103:1007-13.
24. Seo HG, Nishinaka T, Yabe-Nishimura C. Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling. Mol Pharmacol 2000;57:709-17.
25. O'connor T, Ireland LS, Harrison DJ, Hayes JD. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem J 1999;343:487-504.
26. Ramana KV, Bhatnagar A, Srivastava S, et al. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J Biol Chem 2006;281:17652-60.
27. Chen J, Zhao M, Rao R, Inoue H, Hao CM. C/EBPβ and its binding element are required for NF{κ}B-induced COX2 expression following hypertonic stress. J Biol Chem 2005;280:16354-9.
28. Gokmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP. Elevated protein kinase C βII is an early promotive event in colon carcinogenesis. Cancer Res 2001;61:1375-81.
29. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.
30. Kawamura I, Lacey E, Yamamoto N, et al. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice. Anticancer Res 1999;19:4105-11.
31. Kawamura I, Lacey E, Inami M, et al. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI. Anticancer Res 1999;19:4091-7.
32. Shao J, Lee SB, Guo H, Evers BM, Sheng H. Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin. Cancer Res 2003;63:5218-23.
33. Zeindl-Eberhart E, Jungblut PR, Otto A, Kerler R, Rabes HM. Further characterization of a rat hepatoma-derived aldose-reductase-like protein-organ distribution and modulation in vitro. Eur J Biochem 1997;247:792-800.
34. Liu Q, Chan ST, Mahendran R. Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines. Carcinogenesis 2003;24:637-42.
35. Weaver SA, Russo MP, Wright KL, et al. Regulatory role of phosphatidylinositol 3-kinase on TNF-α-induced cyclooxygenase 2 expression in colonic epithelial cells. Gastroenterology 2001;120:1117-27.
36. Han DS, Li F, Holt L, et al. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol 2000;279:G1011-22.
37. Kawaguchi H, Chikazu D, Nakamura K, Kumegawa M, Hakeda Y. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures. J Bone Miner Res 2000;15:466-73.
38. Karim S, Berrou E, Levy-Toledano S, Bryckaert M, MacLouf J. Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells. Biochem J 1997;326:593-9.
39. Donohue PJ, Alberts GF, Hampton BS, Winkles JA. A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase. J Biol Chem 1994;269:8604-9.
40. Hsu DK, Guo Y, Peifley KA, Winkles JA. Differential control of murine aldose reductase and fibroblast growth factor (FGF)-regulated-1 gene expression in NIH 3T3 cells by FGF-1 treatment and hyperosmotic stress. Biochem J 1997;328:593-8.
41. Jacquin-Becker C, Labourdette G. Regulation of aldose reductase expression in rat astrocytes in culture. Glia 1997;20:135-44.
42. Ramana KV, Friedrich B, Tammali R, West MB, Bhatnagar A, Srivastava SK. Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes 2005;54:818-29.
43. Rang ES, Kim HJ, Paek KS, et al. Phorbol ester upregulates aldose reductase expression in A549 cells: a potential role for aldose reductase in cell cycle modulation. Cell Mol Life Sci 2005;62:1146-55.
44. Rao PV, Maddala R, John F, Zigler JS, Jr. Expression of nonphagocytic NADPH oxidase system in the ocular lens. Mol Vis 2004;10:112-21.
45. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 2004;279:34643-54.
46. Tacchini L, Dansi P, Matteucci E, Desiderio MA. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 2001;22:1363-71.
47. Temma K, Shimoya K, Zhang Q, et al. Effects of 4-hydroxy-2-nonenal, a marker of oxidative stress, on the cyclooxygenase-2 of human placenta in chorioamnionitis. Mol Hum Reprod 2004;10:167-71.